• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Role of vasopressin and aldosterone in pulmonary arterial hypertension: A pilot study.血管加压素和醛固酮在肺动脉高压中的作用:一项初步研究。
Contemp Clin Trials. 2009 Sep;30(5):392-9. doi: 10.1016/j.cct.2009.04.003. Epub 2009 Apr 16.
2
A pilot study of the effect of spironolactone therapy on exercise capacity and endothelial dysfunction in pulmonary arterial hypertension: study protocol for a randomized controlled trial.螺内酯治疗对肺动脉高压运动能力和血管内皮功能障碍影响的初步研究:一项随机对照试验的研究方案。
Trials. 2013 Apr 2;14:91. doi: 10.1186/1745-6215-14-91.
3
Aldosterone and Mineralocorticoid Receptor Antagonists on Pulmonary Hypertension and Right Ventricular Failure: A Review.醛固酮和盐皮质激素受体拮抗剂在肺动脉高压和右心衰竭中的作用:综述。
Curr Pharm Des. 2020;26(31):3862-3870. doi: 10.2174/1381612826666200523171137.
4
Mineralocorticoid receptor antagonism attenuates experimental pulmonary hypertension.醛固酮受体拮抗剂可减轻实验性肺动脉高压。
Am J Physiol Lung Cell Mol Physiol. 2013 May 15;304(10):L678-88. doi: 10.1152/ajplung.00300.2012. Epub 2013 Mar 1.
5
Effect of vasopressin on a porcine model of persistent pulmonary hypertension of the newborn.血管加压素对新生持续性肺动脉高压猪模型的影响。
Pediatr Pulmonol. 2019 Mar;54(3):319-332. doi: 10.1002/ppul.24248. Epub 2019 Jan 15.
6
Use of vasopressin after Caesarean section in idiopathic pulmonary arterial hypertension.
Br J Anaesth. 2007 Oct;99(4):552-5. doi: 10.1093/bja/aem180. Epub 2007 Jul 27.
7
Eplerenone attenuates pathological pulmonary vascular rather than right ventricular remodeling in pulmonary arterial hypertension.依普利酮可减轻肺动脉高压中的病理性肺血管重构而非右心室重构。
BMC Pulm Med. 2018 Mar 2;18(1):41. doi: 10.1186/s12890-018-0604-x.
8
Plasma aldosterone levels are elevated in patients with pulmonary arterial hypertension in the absence of left ventricular heart failure: a pilot study.在没有左心室心力衰竭的情况下,肺动脉高压患者的血浆醛固酮水平升高:一项初步研究。
Eur J Heart Fail. 2013 Mar;15(3):277-83. doi: 10.1093/eurjhf/hfs173. Epub 2012 Oct 30.
9
Novel therapies for heart failure: vasopressin and selective aldosterone antagonists.
Congest Heart Fail. 2005 Jan-Feb;11(1):21-9. doi: 10.1111/j.1527-5299.2005.03912.x.
10
Effects of vasopressin on right ventricular function in an experimental model of acute pulmonary hypertension.血管加压素对急性肺动脉高压实验模型右心室功能的影响。
Crit Care Med. 2002 Nov;30(11):2548-52. doi: 10.1097/00003246-200211000-00024.

引用本文的文献

1
Effectiveness of spironolactone plus ambrisentan for treatment of pulmonary arterial hypertension (from the [ARIES] study 1 and 2 trials).螺内酯联合安立生坦治疗肺动脉高压的疗效(来自[ARIES]研究 1 和 2 试验)。
Am J Cardiol. 2013 Sep 1;112(5):720-5. doi: 10.1016/j.amjcard.2013.04.051. Epub 2013 Jun 7.
2
Aldosterone inactivates the endothelin-B receptor via a cysteinyl thiol redox switch to decrease pulmonary endothelial nitric oxide levels and modulate pulmonary arterial hypertension.醛固酮通过半胱氨酸硫醇氧化还原开关使内皮素-B 受体失活,从而降低肺内皮细胞一氧化氮水平并调节肺动脉高压。
Circulation. 2012 Aug 21;126(8):963-74. doi: 10.1161/CIRCULATIONAHA.112.094722. Epub 2012 Jul 11.

本文引用的文献

1
Hyponatremia predicts right heart failure and poor survival in pulmonary arterial hypertension.低钠血症预示着肺动脉高压患者右心衰竭及生存率低下。
Am J Respir Crit Care Med. 2008 Jun 15;177(12):1364-9. doi: 10.1164/rccm.200712-1876OC. Epub 2008 Mar 20.
2
Decreased effective blood volume in edematous disorders: what does this mean?水肿性疾病中有效血容量减少:这意味着什么?
J Am Soc Nephrol. 2007 Jul;18(7):2028-31. doi: 10.1681/ASN.2006111302. Epub 2007 Jun 13.
3
Relationship between admission serum sodium concentration and clinical outcomes in patients hospitalized for heart failure: an analysis from the OPTIMIZE-HF registry.因心力衰竭住院患者入院时血清钠浓度与临床结局的关系:来自OPTIMIZE-HF注册研究的分析
Eur Heart J. 2007 Apr;28(8):980-8. doi: 10.1093/eurheartj/ehl542. Epub 2007 Feb 19.
4
Water and sodium retention in edematous disorders: role of vasopressin and aldosterone.水肿性疾病中的水钠潴留:血管加压素和醛固酮的作用
Am J Med. 2006 Jul;119(7 Suppl 1):S47-53. doi: 10.1016/j.amjmed.2006.05.007.
5
Renal hyporesponsiveness to brain natriuretic peptide: both generation and renal activity of cGMP are decreased in patients with pulmonary hypertension.肾脏对脑钠肽反应低下:肺动脉高压患者中cGMP的生成及肾脏活性均降低。
Peptides. 2006 Nov;27(11):2993-9. doi: 10.1016/j.peptides.2006.05.023. Epub 2006 Jul 5.
6
Role of diminished renal function in cardiovascular mortality: marker or pathogenetic factor?肾功能减退在心血管死亡率中的作用:标志物还是致病因素?
J Am Coll Cardiol. 2006 Jan 3;47(1):1-8. doi: 10.1016/j.jacc.2005.07.067. Epub 2005 Dec 15.
7
Clinical classification of pulmonary hypertension.肺动脉高压的临床分类
J Am Coll Cardiol. 2004 Jun 16;43(12 Suppl S):5S-12S. doi: 10.1016/j.jacc.2004.02.037.
8
Reflex effects of stimulating baroreceptors in the pulmonary artery.刺激肺动脉压力感受器的反射效应。
J Physiol. 1963 Apr;166(1):197-210. doi: 10.1113/jphysiol.1963.sp007100.
9
Renal hemodynamics and sodium excretion in dogs with graded valvular damage, and in congestive failure.患有不同程度瓣膜损伤及充血性心力衰竭的犬的肾血流动力学和钠排泄
Am J Physiol. 1961 Mar;200:601-8. doi: 10.1152/ajplegacy.1961.200.3.601.
10
Acute hemodynamic effects of conivaptan, a dual V(1A) and V(2) vasopressin receptor antagonist, in patients with advanced heart failure.双重血管加压素V(1A)和V(2)受体拮抗剂考尼伐坦对晚期心力衰竭患者的急性血流动力学影响
Circulation. 2001 Nov 13;104(20):2417-23. doi: 10.1161/hc4501.099313.

血管加压素和醛固酮在肺动脉高压中的作用:一项初步研究。

Role of vasopressin and aldosterone in pulmonary arterial hypertension: A pilot study.

机构信息

Division of Renal Disease and Hypertension, University of Colorado Denver, Aurora, Colorado, USA.

出版信息

Contemp Clin Trials. 2009 Sep;30(5):392-9. doi: 10.1016/j.cct.2009.04.003. Epub 2009 Apr 16.

DOI:10.1016/j.cct.2009.04.003
PMID:19375522
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2728149/
Abstract

Much has been learned about the pathophysiological state that underlies the development of increased total body volume and edema in left ventricular failure. Very little, however, is known about the mechanism underlying systemic hypervolemia in patients with isolated right ventricular dysfunction. In this manuscript, we describe our randomized clinical trial to assess the relationship between severity of pulmonary arterial hypertension and neurohormonal activation, total plasma volume and renal function. We assess the role of aldosterone and vasopressin in volume retention in patients with pulmonary arterial hypertension with right ventricular failure. As understanding of the pathogenesis of left ventricular failure has been associated with improved therapies, the better understanding of the mechanisms of isolated right ventricular cardiac failure will also lead to improved patient care.

摘要

关于左心室衰竭时全身血容量增加和水肿形成的病理生理状态,已经有了很多了解。然而,对于单纯右心室功能障碍患者全身性血容量过多的机制却知之甚少。在本文中,我们描述了一项随机临床试验,以评估肺动脉高压严重程度与神经激素激活、全血浆容量和肾功能之间的关系。我们评估了醛固酮和血管加压素在肺动脉高压伴右心衰竭患者容量潴留中的作用。随着对左心室衰竭发病机制的了解,已经出现了改善治疗的方法,因此,对单纯右心室心力衰竭机制的更好理解也将导致患者护理的改善。